Amarin Corp. (AMRN) Tops Q4 EPS by 4c, Revs Beat; Reaffirms
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Amarin Reports Record Fourth Quarter and Full Year 2019 Financial Results and Provides Update on Operations
February 25, 2020 4:06 PM ESTRecord Revenue of $429.8 Million and $143.3 Million for Full Year and Fourth Quarter 2019Â Â
Launch Commenced of VASCEPA® as First and Only Drug with Its New Cardiovascular Risk Reduction Indication
Management to Host Conference Call at 4:30 p.m. ET Today
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today announced financial results for the quarter and year ended December 31, 2019 and provided an update on company operations.
Key Amarin recent achievements... More
